» Articles » PMID: 17382656

Gastroesophageal Reflux in Patients with Idiopathic Pulmonary Fibrosis Referred for Lung Transplantation

Overview
Date 2007 Mar 27
PMID 17382656
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The association between gastroesophageal reflux disease and idiopathic pulmonary fibrosis has not been fully characterized. The aims of this study were to determine in patients with idiopathic pulmonary fibrosis (1) the prevalence of reflux symptoms, (2) the esophageal manometric profile, and (3) the prevalence of proximal and distal esophageal reflux.

Methods: Between May 1999 and March 2006, 30 patients with idiopathic pulmonary fibrosis were referred to the Swallowing Center at the University of California San Francisco. Each patient underwent a structured symptom assessment, esophageal manometry, and 24-hour dual sensor ambulatory pH monitoring.

Results: Twenty (67%) patients had abnormal esophageal reflux. Typical reflux symptoms, although more common in those with reflux, were not reliable as a screening test (sensitivity 65%, specificity 71%). Sixty-five percent of patients with abnormal reflux had a hypotensive lower esophageal sphincter. Abnormal esophageal peristalsis was more common among those with reflux (50% vs 10%; P = .03). In 9 (30%) patients, acid refluxed into the proximal esophagus for over 1% of the study time.

Conclusions: A majority of patients with idiopathic pulmonary fibrosis have pathologic reflux. Symptoms do not distinguish between those with and without reflux. In these patients, reflux is associated with a hypotensive lower esophageal sphincter and abnormal esophageal peristalsis, and often extends into the proximal esophagus.

Citing Articles

Prevalence of Gastroesophageal Reflux in Interstitial Lung Diseases Clinic.

Akhter N, Sumalani K, Chawla D, Rizvi N Cureus. 2025; 16(12):e76454.

PMID: 39866988 PMC: 11769694. DOI: 10.7759/cureus.76454.


Examining Cough's Role and Relief Strategies in Interstitial Lung Disease.

Lim C, Khan S, Alsibai T, Sathiyamoorthy G J Clin Med. 2025; 14(1.

PMID: 39797373 PMC: 11721155. DOI: 10.3390/jcm14010291.


Abnormal bolus reflux on impedance-pH testing independently predicts 3-year pulmonary outcome and mortality in pulmonary fibrosis.

Bailey M, Borges L, Goldberg H, Hathorn K, Gavini S, Lo W J Gastroenterol Hepatol. 2023; 38(11):1998-2005.

PMID: 37605548 PMC: 10761196. DOI: 10.1111/jgh.16325.


Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat?.

Ruaro B, Pozzan R, Confalonieri P, Tavano S, Hughes M, Cerinic M Pharmaceuticals (Basel). 2022; 15(8).

PMID: 36015181 PMC: 9412643. DOI: 10.3390/ph15081033.


Systems Biology and Bile Acid Signalling in Microbiome-Host Interactions in the Cystic Fibrosis Lung.

Woods D, Flynn S, Caparros-Martin J, Stick S, Reen F, OGara F Antibiotics (Basel). 2021; 10(7).

PMID: 34202495 PMC: 8300688. DOI: 10.3390/antibiotics10070766.